Skip to content
TrackPodcasts
healthMar 31, 202312:41pending

PubReading [319] - The Science Behind NMN—A Stable, Reliable NAD+ Activator and Anti-Aging Molecule - Christopher Shade

PubReading

About this episode

In June of 2018, the World Health Organization (WHO) released the 11th edition of its International Classification of Diseases, and for the first time added aging. The classification of aging as a disease paves the way for new research into novel therapeutics to delay or reverse age-related illnesses such as cancer, cardiovascular and metabolic disease, and neurodegeneration. Nutrient sensing systems have been an intense focus of investigation, including mTOR (the mammalian target of rapamycin) for regulating protein synthesis and cell growth; AMPK (activated protein kinase) for sensing low energy states; and sirtuins, a family of seven proteins critical to DNA expression and aging, which can only function in conjunction with NAD+ (nicotinamide adenine dinucleotide), a coenzyme present in all living cellsIntegr Med (Encinitas).2020 Feb;19(1):12-14.

Get every episode summarized

Each time PubReading publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

PubReading [319] - The Science Behind NMN—A Stable, Reliable NAD+ Activator and Anti-Aging Molecule - Christopher Shade

PubReading

0:00
12:41

More episodes

More from PubReading

View all episodes →